BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial

Overview of attention for article published in Annals of the Rheumatic Diseases, May 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

So far, Dimensions has found 5 publications that cite this research output.

Article in Annals of the Rheumatic Diseases (August 2024)

Article in Trends in Pharmacological Sciences (August 2024)

Article in Nature Reviews Rheumatology (August 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.